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Summary 
Increased levels of serum IgE and eosinophilia have been described in human immunodeficiency 
virus (HIV) infection, almost exclusively in patients with CD4 + cell count <200 cells//zl.  IgE 
production is regulated by CD4 + T  helper type 2 (Th-2) lymphocytes, producing interleukin 
4 (IL-4) and expressing a ligand for the B cell-specific CD40 molecule (CD40 ligand [L]).  A 
shift to a Th-2-1ike pattern of cytokine secretion has been postulated to be associated with progression 
toward acquired immunodeficiency syndrome (AIDS). We studied three AIDS patients with 
very high levels of IgE and almost complete depletion of CD4 + lymphocytes, suggesting that 
IgE synthesis could not be driven by CD4 + cells.  IgE in vitro synthesis by cells from such 
patients was, however, inhibited by anti-IL-4.  We show that both CD8 + T  cell lines and the 
majority of CD8 + T  cell clones derived from these patients produce IL-4, IL-5,  and IL-6 in 
half of the cases together with interferon "y (IFN-3').  44%  of CD8 §  T  cell clones expressed 
a CD40L, and the supernatants of the clones were capable of inducing IgE synthesis by normal 
B cells costimulated with anti-CD40.  CD8 + T  cells in these patients  therefore functionally 
mimic Th-2 type cells and may account for hyper-IgE and eosinophilia in the absence of CD4 + 
cells.  The  presence  of such  CD8 +  cells  may also  provide  a  source  of IL-4  directing  the 
development of predominant Th-2 responses in HIV infection. 
I 
ncreased levels of serum IgE and eosinophilia have been 
described in human immunodeficiency virus (HIV-1) in- 
fection, almost exclusively in patients with CD4 + cell count 
below 200 cells/#l (1, 2). Serum IgE levels were raised two- 
to fivefold above normal values, without accompanying symp- 
toms of atopic diseases, which frequently develop in HIV + 
subjects  (3). IgE production is regulated by CD4 + T helper 
(Th) lymphocytes expressing a ligand for the CD40 mole- 
cule (4, 5), whose binding induces B cell responsiveness to 
IL-4 and IL-10. These cytokines, produced by Th-2 cells, are 
able to promote B cell switch and Ig production (6). CD4 + 
Th-2 cells are also the main source of other cytokines, such 
as IL-5, which drives the development and activation of eo- 
sinophils,  together with GM-CSF (7). A shift from a Th-1- 
like to a Th-2-1ike pattern of cytokine secretion has been postu- 
lated to be associated  with progression towards AIDS (8), 
with increased production of IL-4, compared with IL-2, in 
the in vitro response to recall antigens, and raised IL-10 produc- 
tion (9). 
Several studies have recently reported IL-4 production by 
non-CD4 § cell types (10), including CD8 § cells (11, 12). 
IL-4 produced by non-CD4 + cells is unable to induce IgE 
responses in IL-4 knockout mice reconstituted with CD4- 
cells from spleen of congenic type mice (13), although these 
cells may support already established IgE responses. The effect 
of depletion of CD4 + cells on IgE production has not been 
investigated so far. In a selected group of AIDS patients with 
very high levels of IgE (20- to >100-fold above normal values) 
we found an almost complete depletion of CD4 § lympho- 
cytes, suggesting that these cells may not be the source of 
IL-4 driving IgE synthesis. These patients also presented se- 
vere atopic symptoms and hypereosinophilia (14), and thus 
represented a possible  model to study the contribution of 
CD4-  cells to Th-2 type of responses.  The production of 
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as well as the ability to express a CD40 ligand (CD40L), 
and to stimulate IgE synthesis by normal B lymphocytes, in- 
dicate that these cells can functionally mimic CD4 + Th-2 
cells and account for the clinical features presented by AIDS 
patients with hyper-IgE. 
Materials and Methods 
Patients.  We studied three male patients (age 32-59 yr) affected 
by AIDS, with very high levels of IgE (serum levels were 12,000, 
2,600, and 3,400 kU/L, respectively),  eosinophilia  (900 _+ 150 cell/ 
mm3), chronic diffuse  pruritic dermatitis, repeated Staphylococcal 
abscesses, and Candida infections. These patients had CD4* ceil 
counts of 0.4, 5, and 0.3% of  peripheral blood lymphocytes  (PBL), 
respectively, corresponding to absolute numbers of 1,38, and 4 
CD4 + cells/#l. Parasites were absent, both in skin and stools, and 
no other known cause of eosinophilia was found. 
Flow Cytometric Analysis.  For double fluorescence  analysis  calls 
were stained with the following mAbs, PE- or FITC-conjugated: 
anti-CD3 (Leu 4), anti-CD4 (Leu 3a), anti-CD8 (Leu 2a, all from 
Becton Dickinson Immunocytometry Systems, Mountain View," 
CA). A chimeric molecule generated by fusing the extracellular 
domain of CD40 to the heavy chain of IgG1 (a kind gift of I. 
Stamenkovic, Harvard University, Cambridge, MA), was used for 
the determination of CD40L expression on the surface of T calls, 
and  revealed by  indirect  immunofluorescence with  a  FITC- 
conjugated F(ab)z goat antiserum to human IgG (Serotec, Oxford, 
UK). Normal polyclonal human IgG were used as control. Flow 
cytometric  analysis  was performed  on a Cytoron (Ortho Diagnostic 
Systems, Raritan, NJ) after electronic gating on lymphocytes. 
Mononuclear Cell  Cultures.  Lymphoprep (Nycomed,  Oslo, 
Norway)-separated PBMC  were resuspended in  RPMI  1640 
(GIBCO BRL, Gaithersburg, MD) supplemented  with 100 U/ml 
penicillin and 100/zg/ml streptomycin  (GIBCO BILL),  2 mM t-glu- 
tamine (GIBCO BRL) and 10% FCS (Hyclone,  Logan, UT) (com- 
plete medium) at 106 ceUs/ml. Duplicate cultures of 1 ml were 
set up for 10 d, with or without the following: cycloheximide 
(100/~g/ml; Sigma  Chemical  Co., St. Louis,  MO), and goat neutra- 
lizing anti-I1,4 (K&D Systems,  Inc., Minneapolis, MN), or normal 
goat serum as control, at different concentrations (1-100/zg/ml). 
Supernatants were then collected and stored in aliquots at -80~ 
for up 3 wk until analysis for IgE determinations. 
The induction of IgE synthesis by normal B ceils from three 
healthy  controls  was tested  by adding  anti-CD40 (mAb 89, 0.5/zg/ml, 
a kind gift of  Dr. J. Banchereau,  Schering-Plough,  Dardilly,  France) 
with or without I1,4 100 U/ml, or 1:10 dilution of supernatants 
from six CD8 + T cell clones from patient 1. B lymphocytes were 
obtained from PBMC by immunomagnetic selection with anti- 
CD3-coated  beads (Dynal, Oslo, Norway). 2  x  10  s negatively 
selected cells were cultured for 7 d and supernatants collected for 
IgE determination. 
Immunomagnetic depletion of CD8 + PBMC was performed  by 
using anti-CD8-coated immunobeads (Dynal). After depletion, 
CD8 + cells were always <1%.  CD8-depleted PBMC were cul- 
tured for 7 d at 0.5  x  106 cells/ml and supernatants were tested 
for IgE synthesis as described. 
Generation of T  Cell Lines and Clones.  Patients'  PBMC were 
stimulated with PHA-P (1/zg/ml; Wellcome, Beckenham, UK) 
in 24-well  flat-bottomed  phtes (Falcon, Oxnard, CA). rI1,2 (20 U/m1; 
Boehringer Mannheim, Mannheim, Germany)  was then added, and 
after 6 d, viable T bhsts resuspended in complete medium (sup- 
plemented with 2-MER 50 #M; Sigma Chemical  Co.) were seeded 
at 0.6 cell/weU in U-bottomed 96-wells plates (Falcon). 2  x  105 
irradiated (6,000 tad from Cs source) allogeneic  mononuclear cells 
were used as feeders. After 2 wk, growing wells were identified 
using an inverted microscope, and expanded by weekly splitting 
and addition of riD2 supplemented complete medium. T cell lines 
were also cultured in bulk with rib2 addition. 
Determination of lgE in Supernatants.  IgE in culture superna- 
tants were measured  by a modified  paper radioimmunosorbent  assay, 
as described  previously  (15). Bdefy, paper disks coated  with anti-IgE 
(Pharmacia LKB, Uppsala, Sweden) were incubated with 200 #I 
of the supernatants overnight, then washed and reincubated with 
1:4 dilution of 125I-labeled anti-IgE (200 #1; Pharmacia LKB) for 
18 h. After four washes, bound radioactivity was read against dilu- 
tions of the IgE standards, down to 100 pg/ml of IgE. 
In all subsequent calculations, the amount of IgE measured in 
cultures supplemented with the protein synthesis inhibitor cyclo- 
heximide were subtracted from the results of  both spontaneous or 
stimulated samples, to obtain the value of IgE synthesized, dis- 
regarding the amount of cell-bound IgE preformed and released 
in culture. 
Cytokine Detection.  Supernatants of T cell lines were collected 
48 h after restimulation with anti-CD3 (14 rig/m1) or at the same 
time after addition of 20 U/m1 rib2, whereas supernatants of T 
cell clones were studied 24 h after addition of rlL-2 or ri1,2 plus 
anti-CD3. Cytokine production was determined in supernatants 
from T cell lines and clones using the following ELISA kits: Hu- 
IFN-3, ELISA (Hbt, Amsterdam, The Netherlands), II,4, I1,5,11,6 
ELISA (Quantikine  TM, R&D Systems, Inc.), 11,10 ELISA (Bender 
MedSystems, Vienna, Austria). All samples were tested in dupli- 
cate and thawed  only once. Measurements  were performed  according 
to the manufacturers' instructions, and results interpolated from 
the standard reference curve provided with each kit. 
Reverse Transc@tase-Polymerase  Chain Reaction (RT-PCR) Analysis. 
Total cellular RNA was extracted as described by Chomczynski 
and Sacchi (16). RT-PCR was performed as previously described 
(17). Briefly, cDNA was derived from total RNA (1.5/~g/30 #1 
reaction), incubated for 10 rain at 65~  with 0.1/~g/ml oligo-dT 
(12-18 mer; Pharmacia LKB). After cooling on ice, 20 U/ml of 
Moloney murine leukemia  virus (M-MLV) RT, 20 mM dithiothre- 
itol (DTT), and 5 x M-MLV RT buffer were added, according to 
manufacturer's instructions (GIBCO BRL). The cDNAs thus ob- 
tained were tested for the presence of specific gene sequences in 
PCR reactions (GeneAmp  kit; Perkin-Elmer  Cetus, Norwalk, CT) 
performed in 20/zl volumes, by using defined primers' pairs. 2 #1 
of the relevant eDNA was amplified in the presence of 0.05/~M 
final concentration of 5' and 3' primers, 2 mM deoxi-nudeotides 
and 0.5 U of ampliTaq  polymerase  and GenAmp 10x  PCR buffer. 
The PCR was performed in a Perkin Elmer thermal cycler  for 25 
cycles: 40-s denaturation  at 94~  40-s annealing  at 62~  and 1-min 
extension at 72~  The reaction product was visualized by dec- 
trophoresis, on 1% agarose gel, using 10/~1 of the reaction mix- 
ture and 2 #1 of loading buffer. 0.5/zg of HaelII-digested ~X174 
DNA (GIBCO BILL) were run in parallel as molecular weight 
markers, providing bands at 1,353, 1,078,872, 603, 310, 281, and 
234 bp. Cytokine specific primer pairs were synthesized on syn- 
thesizer (Applied Biosystems  Inc., Foster City, CA) according to 
published sequences (17, 18). The primer sequences were RNA 
specific. 
Results and Discuuion 
Phenotypes of Cells Ex  Vivo and in IL-2-dependent  T  Cell 
Clones.  The dramatic decrease of CD4 + cells in vivo was 
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Figure  1.  Spontaneous  in vitro synthesis of IgE by PBMC from pa- 
tients with AIDS and hyper-IgE (Pat. 1-3, A, solid Mrs). 106 PBMC were 
cultured for 10 d and IgE content in the supernatants measured by paper 
radioimmunoassay. The effect of addition of neutralizing goat anti-human 
Ib4 antibody (1-100/~g/ml, B-D) at the beginning of cultures is shown. 
No inhibition was observed with control unimmunized goat serum. IgE 
detected in cycloheximide (100 #g/ml)-treated cultures have been subtracted, 
to obtain net de novo  synthesis. 
accompanied by a relative increase of CD8 + T lymphocytes 
(58  _+ 14%), whose absolute count was only slightly raised, 
due to the low number of total CD3 + T  lymphocytes (av- 
erage mean, 569 cells//~l). T cell lines were grown from PBMC 
of the patients, and maintained in rlL-2, after initial stimula- 
tion with PHA.  Cloning of cells from two lines (patients 
1 and 2) was then performed, and growing T cell clones were 
analyzed 2 mo after seeding. All three cell lines, 24/24 clones 
from patient 1 and 26/28 from patient 2 were CD3 +  CD8 + 
CD4-,  with ~>99% of the cells expressing this phenotype. 
The remaining two clones were respectively CD3 +CD4 + 
CD8-  and CD3+CD4+CD8 +. The almost complete deple- 
tion of circulating CD4 + cells was then reproduced also at 
clonal level in these patients. 
Spontaneous In Vitro Synthesis of lgE by PBMC of AIDS 
Patients.  PBMC from the three patients were cultured for 
spontaneous IgE production for 10 d, and in all instances, 
net IgE synthesis in supernatants was present at levels ranging 
from 10.3 to 144.6 ng/ml (Fig. 1, solid bars). No spontaneous 
net IgE production was detected in cultures from HIV nonin- 
fected nonatopic subjects (data not shown). The levels of IgE 
found in cultures from HIV + cases with hyper-IgE were 
similar to those obtained in cultures of PBMC from patients 
affected by the primary hyper-IgE syndrome (15), a primary 
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Figure 2.  IgE synthesis by CD8-depleted PBMC from a patient with 
HIV + hyper-lgE syndrome compared with unseparated cells. A represen- 
tative experiment of three is shown. 
immunodeficiency  disease in which clinical features are closely 
related to those observed in our HIV + cases (19), and where 
an imbalance between IL-4 and IFN-v production has been 
reported (15, 19, 20). These two cytokines are known to exert 
opposing effects on IgE (21), and their balance ought to be 
critical in hyper-IgE states. 
We therefore asked whether IL-4 was playing a role in the 
in vitro spontaneous synthesis of IgE occurring in patients 
severely depleted of CD4 + cells, the principal producers of 
IL-4 in immune responses.  Addition of increasing amounts 
of neutralizing antibody to IL-4 inhibited IgE production 
in vitro in a dose-dependent fashion in the range 1-100 #g/ml 
(Fig.  1, empty bars), indicating that presence of IL-4 was es- 
sential for de novo synthesis of IgE in vitro. A control nonim- 
munized goat serum had no effect upon levels of IgE detected 
in the culture supernatants (data not shown). 
CD4 + cells were severely reduced in these patients,  and 
CD8 + cells accounted for 93-99% of all T lymphocytes. We 
observed that depletion of these CD8 + cells led to a 6-10- 
fold reduction of IgE synthesis (Fig. 2). We therefore postu- 
lated that these cells might be an alternative source of IL-4 
in our cases, and might be actively promoting IgE produc- 
tion through IL-4. 
Cytokine Production by PBMC, T Cell Lines, and Clones.  Su- 
pernatants from PHA-stimulated PBMC of the three patients 
were analyzed by ELISA, and IL-4 was detected at different 
concentrations (40-1,600  pg/ml).  CD8 + T  call lines also 
produced IL-4 (150-490 pg/ml) upon stimulation by mono- 
aloha1 anti-CD3 antibody, mRNAs for IL-4, IL-5, and GM- 
CSF were detected by RT-PCR,  as shown in Fig. 3 for the 
CD8+CD4 -  T  cell  line  from patient  2.  These mRNAs 
were present both in CD8 + T  cells cultured in rIL-2, and 
after restimulation with anti-CD3;  in the latter condition 
the amount detected seemed to increase. The presence of p55 
IL-2 receptor chain RNA showed that the cells were acti- 
vated in both conditions. IL-5 and GM-CSF are known to 
promote eosinophil differentiation, growth and activation (7, 
22). Thus their production by CD8 + T cells may be related 
to eosinophilia in these patients.  No mRNA for IL-2 and 
IFN-3, was detected in this cell line, despite maximal stimu- 
lation.  This cytokine pattern is usually detectable in Th-2 
type cells, but it has been reported under certain conditions 
also in CD8 + lymphocytes (11, 12,  23,  24).  Further anal- 
ysis was made on supernatants of CD8 § T  cell clones by 
ELISA for different cytokines. Data reported in Table 1 dem- 
onstrate that a complex mix of cytokine production could 
be detected in the CD8 + clones from both patient 1 and 2. 
67% of the CD8 + clones produced measurable amounts of 
IL-4, 52% IL-10,  and 72% also IFN-% IL-5 and IL-6 were 
consistently detected in all supernatants tested, ranging respec- 
tively from 50->2,500 pg/ml and from 18-~>3,000 pg/ml. 
Not  included  in  the  table,  the  supernatant  of the  only 
CD4 +/CD8 + clone from patient 2 contained IFN-7 only, 
whereas the CD4 + clone from the same patient was a typ- 
ical Th-2 cell, producing IL-4, IL-5, and IL-10 but no IFN-% 
In 42%  of the CD8 + clones we observed both IL-4 and 
IFN-~, production. This is consistent with previous reports 
showing that a fraction of alloreactive routine (23) and human 
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IL-4  IFN-y  No.  Percent  Percent  IL-10 + 
+  +  17  42.5  76.4 
+  -  10  25  60 
-  +  12  30  16.6 
-  -  1  2.5  0 
Supernatants  of 40 CD8 + T cell clones from patients  1 and 2 were ana- 
lyzed by F.LISA for cytokine content. IL-5 and IL-6 were present in all, 
with levels ranging from 50 to >2,500 pg/ml, and 18 to >3,000 pg/ml, 
respectively. Number and percentage of 1I,-4 and/or IFN-3' producer clones 
are  given.  In  the last  column,  the percentage  of clones  in  each row 
coproducing also IL-10 is indicated. 
cell clones was further suggested by the expression of a CD40L 
on the surface of the cells.  This was tested using a fusion 
product of CD40 with human IgG1 heavy chain, and de- 
tected by cytofluorimetry. 22 out of 50 CD8 + T  cell clones 
examined after 72 h of culture with rlL-2 expressed a CD40L 
(Fig.  4, illustrating two representative positive clones from 
each patient). Only a small minority of CD8 + T  lympho- 
cytes have been reported to express a CD40L after activation 
(27),  whereas nearly half of the CD8 + clones derived from 
HIV + patients  with hyper-IgE had a stable  expression of 
this molecule. In a patient with primary hyper-IgE syndrome, 
only CD4 +,  but  no  CD8 +,  T  cell clones  expressed the 
CD40L (data not reported). However, preliminary data from 
AIDS  patients  without  features  of hyper-IgE  show  that 
CD40L  is  expressed by CD8 + clones under the same ex- 
Figure  3.  Detection of mRNA for cytokines by RT-PCR in PBMC 
of a normal control (A) and a CD8 + T  cell line from patient  2 (B-C). 
(A) Normal PBMC tested 48 h after stimulation with anti-CD3 (14 ng/ml) 
and rib2.  (B) T  cell line 48 h after readdition of rlL-2 (20 U/ml). (C) 
T cell line 48 h after restimulation with anti-CD3 and rlb2. 2/~1 ofcDNA 
were subjected to 25 cycles of amplification by using defined primers' pairs 
synthesized according to published sequences (17, 18). The product of PCR 
was visualized by electrophoresis  on 1% agarose gel.  Molecular weight 
markers are indicated by the arrow, providing bands at 1,353, 1,078, 872, 
603,  310, 281, and  234 bp. 
(24,  25) CD8 + cell clones have the capacity to secrete both 
cytokines,  despite  the  majority of CD8 +  clones  produce 
IL-2 and IFN-3, but no IL-4. Thus,  the ability of both T 
cell lines and about 25%  of CD8 + T  cell clones to secrete 
exclusively Th-2 type cytokines after stimulation may be re- 
garded as  an abnormal expansion of a CD8 + subset with 
helper activity. Previous in vivo priming by IL-4 producing 
Th  cells,  as  demonstrated by in  vitro priming  of murine 
CD8 + cells (26)  might account for the appearance of this 
type of cell. In HIV infection a shift to preferential produc- 
tion of IL-4 has been in fact observed (8). 
CD40L Expression  by Stimulated CD8 + Cells.  The pos- 
sibility of a direct induction of IgE synthesis by CD8 + T 
'  '  '  D 
Relative fluorescence 
Figure  4.  Expression of CD40L on the surface of CD8 § T cell clones 
from AIDS patients  with hyper-IgE.  Cells were stained after 72 h of cul- 
ture in medium with rlL-2 (20 U/ml), with a chimeric CD40-human  IgG1 
molecule (clear  histogram)  or with polyclonal human IgG (control, in black), 
followed by FITC-F(ab)2 goat anti-human IgG. Mean fluorescence inten- 
sity channel was over twice control values on a linear scale in the positive 
clones. Four representative CD8 + T cell clones expressing a CD40L are 
shown:  nos.  1 (a) and 10 (b) from patient  1,  and nos. 19 (c) and 33 (d) 
from patient  2. 
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Figure  5.  In vitro synthesis  of IgE by normal B cells induced  by anti- 
CD40 and rib4 or CD8 + T cell clones supematants. B cells were nega- 
tively selected  from normal PBMC by immunomagnetic  depletion  with 
anti-CD3-coated beads. 2 x 10  s B cells were cultured  for 7 d in the pres- 
ence of anti-CD40 (mAb 89, 0.5 #g/m1), and rlI,4 (100 U/m1), or 1:10 
dilutions of supernatants of CD8 + T cell clones  nos. 1, 2, 6, 10, 13, and 
24 from  patient 1. IgE levels  below 100 pg/ml are indicated  as undetectable. 
perimental conditions (Paganelli, R., manuscript in prepa- 
ration). 
The presence of CD8 + lymphocytes expressing a CD40L, 
and able to produce IL-4, IL-5, and GM-CSF suggests that 
these cells are directly capable of causing the main features 
of this HIV-associated syndrome, i.e., hyper-IgE production 
and eosinophilia. 
Induction of lgE Synthesis  by CD8 + T  Cell Clones Superna- 
tants.  Since both IL-4 and IFN-y were produced, alone or 
in combination, by the majority of T cell clones examined, 
we tested the effects of the addition of clone supernatants 
on the in vitro production of IgE by normal B lymphocytes. 
B cells purified from a normal individual were cultured for 
7 d in the presence  of anti-CD40, without or with either 
100 U/ml rlL-4 (positive control), or 1:10 dilutions of six 
different CD8 + T  cell clones supernatants from patient 1. 
All six selected clones produced IL-4 (15-60 pg/ml), but five 
of the six also secreted IFN-% In five cases the addition of 
the supernatants resulted in the stimulation of IgE synthesis 
above control cultures with anti-CD40 alone (Fig.  5). This 
shows that CD8 + T cells from HIV § patients with hyper- 
IgE have the characteristics  of Th-2 type cells, directly in- 
ducing IgE synthesis by normal B cells. These cells may be 
able to drive hyperproduction of IgE, as well as eosinophilia, 
in patients with almost complete depletion of CD4 + lym- 
phocytes. It is possible that CD8 + cells endowed with Th-2 
type competence arise earlier in the course of HIV disease, 
and may be the source of IL-4 directing CD4 + cells to shift 
toward a Th-2 phenotype (28). The expansion of this subset 
of CD8 + cells may account for the clinical  aspects  mani- 
fested by a small proportion of patients with advanced stage 
of HIV disease. Alternatively these CD8 + cells may appear 
as a consequence of the prevailing  Th-2 type of response in 
HIV infection (8),  and this would be consistent with the 
presence of increased IgE levels in the late phase of HIV dis- 
ease, parallel  to the decrease of CD4 + cells (2,  3). 
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